Published in PLoS One on July 13, 2011
Key role of CRF in the skin stress response system. Endocr Rev (2013) 1.77
Corticotropin-Releasing Hormone Receptor 2 Signaling Promotes Mucosal Repair Responses after Colitis. Am J Pathol (2015) 0.80
Corticotropin-releasing hormone improves survival in pneumococcal pneumonia by reducing pulmonary inflammation. Physiol Rep (2017) 0.75
Wound healing--aiming for perfect skin regeneration. Science (1997) 16.08
In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc (2007) 12.39
The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med (1995) 6.17
The myofibroblast in wound healing and fibrocontractive diseases. J Pathol (2003) 6.16
Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol (1999) 5.58
Keratinocyte-fibroblast interactions in wound healing. J Invest Dermatol (2007) 3.51
Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev (2000) 2.98
Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature (1995) 2.21
Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice. FASEB J (2000) 1.99
Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J (2001) 1.74
Neuroimmunology of stress: skin takes center stage. J Invest Dermatol (2006) 1.72
Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science (1991) 1.70
Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression. FASEB J (2001) 1.59
CRH stimulates POMC activity and corticosterone production in dermal fibroblasts. J Neuroimmunol (2005) 1.42
Transforming growth factor-beta1 induces interleukin-6 expression via activating protein-1 consisting of JunD homodimers in primary human lung fibroblasts. J Biol Chem (1999) 1.39
Delayed and deficient dermal maturation in mice lacking the CXCR3 ELR-negative CXC chemokine receptor. Am J Pathol (2007) 1.38
CRH functions as a growth factor/cytokine in the skin. J Cell Physiol (2006) 1.38
Delayed wound healing in immunodeficient TGF-beta 1 knockout mice. J Invest Dermatol (2000) 1.38
Interleukin-6: molecular pathophysiology. J Invest Dermatol (1990) 1.32
The dynamics of inflammatory cytokines in the healing process of mouse skin wound: a preliminary study for possible wound age determination. Int J Legal Med (1996) 1.10
CRH and the immune system. J Neuroimmunol (1997) 1.10
Regulatory mechanisms of corticotropin-releasing hormone and vasopressin gene expression in the hypothalamus. J Neuroendocrinol (2004) 1.05
Stimulatory effect of corticotropin-releasing neurohormone on human lymphocyte proliferation and interleukin-2 receptor expression. J Neuroimmunol (1989) 1.03
IL-6 modulates alpha-smooth muscle actin expression in dermal fibroblasts from IL-6-deficient mice. J Invest Dermatol (2006) 1.03
Interleukin-6 and the skin. Int Arch Allergy Immunol (1996) 1.01
Corticotropin-releasing hormone affects cytokine production in human HaCaT keratinocytes. Life Sci (2002) 0.99
Hair cycle-dependent expression of corticotropin-releasing factor (CRF) and CRF receptors in murine skin. FASEB J (1998) 0.99
Alanine scanning mutagenesis of the second extracellular loop of type 1 corticotropin-releasing factor receptor revealed residues critical for peptide binding. Mol Pharmacol (2009) 0.97
Involvement of the corticotropin-releasing hormone system in the pathogenesis of acne vulgaris. Br J Dermatol (2008) 0.96
Enhancing effect of corticotropin-releasing neurohormone on the production of interleukin-1 and interleukin-2. Neurosci Lett (1990) 0.96
Corticotropin-releasing hormone regulates IL-6 expression during inflammation. J Clin Invest (2001) 0.94
Corticotropin-releasing hormone modulates cytokines release in cultured human peripheral blood mononuclear cells. Life Sci (1993) 0.91
Interleukin (IL)-6 modulates transforming growth factor-beta expression in skin and dermal fibroblasts from IL-6-deficient mice. Br J Dermatol (2009) 0.90
Corticotropin-releasing hormone deficiency unmasks the proinflammatory effect of epinephrine. Proc Natl Acad Sci U S A (1999) 0.90
Regulation and role of interleukin 6 in wounded human epithelial keratinocytes. Cytokine (2001) 0.90
Evaluation of an automated immunoassay method for cytokine measurement using the Immulite Immunoassay system. Clin Chem Lab Med (1999) 0.87
Interleukin-6 receptor superantagonist Sant7 inhibits TGF-beta-induced proliferation of human lung fibroblasts. Cell Prolif (2008) 0.84
Early alterations of actin cytoskeleton in OK cells by opioids. J Cell Biochem (1998) 0.83
Corticotropin-releasing hormone deficiency results in impaired splenocyte response to lipopolysaccharide. J Neuroimmunol (2003) 0.80
Lessons from CRH knockout mice. Neuropeptides (2002) 0.77
Local expression of corticotropin-releasing hormone in inflammatory arthritis. Ann N Y Acad Sci (1995) 0.77
Kappa opioids exert a strong antiproliferative effect on PC12 rat pheochromocytoma cells. Peptides (1996) 0.76
The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity (2009) 3.58
Beta2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch. J Biol Chem (2002) 2.87
Signalling networks regulating cyclooxygenase-2. Int J Biochem Cell Biol (2006) 2.66
Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization. Proc Natl Acad Sci U S A (2012) 1.97
Systemic levels of interleukin-6 and matrix metalloproteinase-9 in patients with multiple myeloma may be useful as prognostic indexes of bone disease. Clin Chem Lab Med (2005) 1.93
The 'self-plagiarism' oxymoron: can one steal from oneself? Eur J Clin Invest (2012) 1.49
Crucial role of granulocytic myeloid-derived suppressor cells in the regulation of central nervous system autoimmune disease. J Immunol (2011) 1.34
Antiproliferative and apoptotic effects of selective phenolic acids on T47D human breast cancer cells: potential mechanisms of action. Breast Cancer Res (2003) 1.32
Adiponectin induces TNF-alpha and IL-6 in macrophages and promotes tolerance to itself and other pro-inflammatory stimuli. Biochem Biophys Res Commun (2005) 1.26
Neurosteroids as modulators of neurogenesis and neuronal survival. Trends Endocrinol Metab (2008) 1.25
TNF-alpha and obesity. Curr Dir Autoimmun (2010) 1.24
Membrane androgen receptor activation induces apoptotic regression of human prostate cancer cells in vitro and in vivo. J Clin Endocrinol Metab (2004) 1.22
Corticotropin-releasing hormone augments proinflammatory cytokine production from macrophages in vitro and in lipopolysaccharide-induced endotoxin shock in mice. Infect Immun (2002) 1.22
Use of the substituted cysteine accessibility method to study the structure and function of G protein-coupled receptors. Methods Enzymol (2002) 1.21
Modulation of pancreatic islets-stress axis by hypothalamic releasing hormones and 11beta-hydroxysteroid dehydrogenase. Proc Natl Acad Sci U S A (2011) 1.20
Corticotropin-releasing hormone antagonists possess anti-inflammatory effects in the mouse ileum. Gastroenterology (2002) 1.18
Meckel's diverticulum in paediatric practice on Crete (Greece): a 10-year review. Afr J Paediatr Surg (2012) 1.14
Corticotropin-releasing factor and the urocortins induce the expression of TLR4 in macrophages via activation of the transcription factors PU.1 and AP-1. J Immunol (2006) 1.12
cGMP-dependent protein kinase contributes to hydrogen sulfide-stimulated vasorelaxation. PLoS One (2012) 1.12
Adiponectin promotes endotoxin tolerance in macrophages by inducing IRAK-M expression. J Immunol (2009) 1.12
Rho/ROCK/actin signaling regulates membrane androgen receptor induced apoptosis in prostate cancer cells. Exp Cell Res (2008) 1.06
Urocortin 1 and Urocortin 2 induce macrophage apoptosis via CRFR2. FEBS Lett (2005) 1.02
Relationship between serum levels of vascular endothelial growth factor, hepatocyte growth factor and matrix metalloproteinase-9 with biochemical markers of bone disease in multiple myeloma. Clin Chim Acta (2006) 1.02
Akt2 deficiency protects from acute lung injury via alternative macrophage activation and miR-146a induction in mice. J Immunol (2013) 1.01
Dehydroepiandrosterone and allopregnanolone protect sympathoadrenal medulla cells against apoptosis via antiapoptotic Bcl-2 proteins. Proc Natl Acad Sci U S A (2004) 1.01
Vasoactive intestinal peptide suppresses toll-like receptor 4 expression in macrophages via Akt1 reducing their responsiveness to lipopolysaccharide. Mol Immunol (2008) 0.99
Tpl2 and ERK transduce antiproliferative T cell receptor signals and inhibit transformation of chronically stimulated T cells. Proc Natl Acad Sci U S A (2008) 0.99
Neurosteroid dehydroepiandrosterone interacts with nerve growth factor (NGF) receptors, preventing neuronal apoptosis. PLoS Biol (2011) 0.99
Igf2 deficiency results in delayed lung development at the end of gestation. Endocrinology (2006) 0.98
Neurosteroids as endogenous inhibitors of neuronal cell apoptosis in aging. Ann N Y Acad Sci (2006) 0.97
Activation of membrane estrogen receptors induce pro-survival kinases. J Steroid Biochem Mol Biol (2006) 0.97
Alanine scanning mutagenesis of the second extracellular loop of type 1 corticotropin-releasing factor receptor revealed residues critical for peptide binding. Mol Pharmacol (2009) 0.97
Opposing effects of estradiol- and testosterone-membrane binding sites on T47D breast cancer cell apoptosis. Exp Cell Res (2005) 0.96
Leptin mediates Clostridium difficile toxin A-induced enteritis in mice. Gastroenterology (2003) 0.95
Activation of membrane androgen receptors potentiates the antiproliferative effects of paclitaxel on human prostate cancer cells. Mol Cancer Ther (2006) 0.95
Corticotropin-releasing hormone induces Fas ligand production and apoptosis in PC12 cells via activation of p38 mitogen-activated protein kinase. J Biol Chem (2002) 0.95
Corticotropin-releasing hormone deficiency is associated with reduced local inflammation in a mouse model of experimental colitis. Endocrinology (2008) 0.94
Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPS-induced TNF-alpha release from macrophages via induction of COX-2 and PGE2. J Cell Physiol (2007) 0.94
The corticotropin-releasing factor (CRF) family of neuropeptides in inflammation: potential therapeutic applications. Curr Med Chem (2005) 0.93
Juvenile granulosa cell tumor arising from intra-abdominal testis in newborn: case report and review of the literature. Urology (2011) 0.92
The complement anaphylatoxin C5a receptor contributes to obese adipose tissue inflammation and insulin resistance. J Immunol (2013) 0.92
Dual role of B7 costimulation in obesity-related nonalcoholic steatohepatitis and metabolic dysregulation. Hepatology (2014) 0.91
Regulation of nuclear factor-kappaB by corticotropin-releasing hormone in mouse thymocytes. Mol Endocrinol (2002) 0.90
Estrogen exerts neuroprotective effects via membrane estrogen receptors and rapid Akt/NOS activation. FASEB J (2004) 0.90
Association of Prenatal Exposure to Persistent Organic Pollutants with Obesity and Cardiometabolic Traits in Early Childhood: The Rhea Mother-Child Cohort (Crete, Greece). Environ Health Perspect (2015) 0.90
Novel dehydroepiandrosterone derivatives with antiapoptotic, neuroprotective activity. J Med Chem (2009) 0.89
NF-kappaB participates in the corticotropin-releasing, hormone-induced regulation of the pituitary proopiomelanocortin gene. J Biol Chem (2004) 0.88
Corticotropin Releasing Factor promotes breast cancer cell motility and invasiveness. Mol Cancer (2009) 0.88
Expression of the Tpl2/Cot oncogene in human T-cell neoplasias. Mol Cancer (2004) 0.88
Role of platelet-derived growth factor-AB in tumour growth and angiogenesis in relation with other angiogenic cytokines in multiple myeloma. Hematol Oncol (2011) 0.87
Corticotropin-releasing hormone contributes to the peripheral inflammatory response in experimental autoimmune encephalomyelitis. J Immunol (2005) 0.86
Dehydroepiandrosterone: an ancestral ligand of neurotrophin receptors. Endocrinology (2015) 0.86
Corticotropin-releasing factor regulates TLR4 expression in the colon and protects mice from colitis. Gastroenterology (2010) 0.86
G protein-associated, specific membrane binding sites mediate the neuroprotective effect of dehydroepiandrosterone. FASEB J (2006) 0.86
Interleukin-6 genetic ablation protects from trinitrobenzene sulfonic acid-induced colitis in mice. Putative effect of antiinflammatory cytokines. Neuroimmunomodulation (2006) 0.86
The actin cytoskeleton in rapid steroid hormone actions. Cytoskeleton (Hoboken) (2014) 0.84
Alendronate reduces serum TNFalpha and IL-1beta, increases neutrophil counts, and improves bone mineral density and bone metabolism indices in patients with chronic idiopathic neutropenia (CIN)-associated osteopenia/osteoporosis. J Bone Miner Metab (2004) 0.84
APRIL binding to BCMA activates a JNK2-FOXO3-GADD45 pathway and induces a G2/M cell growth arrest in liver cells. J Immunol (2012) 0.84
Total and corrected antioxidant capacity in hemodialyzed patients. BMC Nephrol (2003) 0.83
Genetic dissection of neurotrophin signaling through the p75 neurotrophin receptor. Cell Rep (2012) 0.83
Peripheral factors in the metabolic syndrome: the pivotal role of adiponectin. Ann N Y Acad Sci (2006) 0.82
Rapid genotyping of CYP2D6, CYP2C19 and TPMT polymorphisms by primer extension reaction in a dipstick format. Anal Bioanal Chem (2007) 0.82
Differential effects of dehydroepiandrosterone and testosterone in prostate and colon cancer cell apoptosis: the role of nerve growth factor (NGF) receptors. Endocrinology (2013) 0.81
Rational design, efficient syntheses and biological evaluation of N,N'-symmetrically bis-substituted butylimidazole analogs as a new class of potent Angiotensin II receptor blockers. Eur J Med Chem (2013) 0.81
G protein-coupled receptor signaling to Kir channels in Xenopus oocytes. Curr Pharm Biotechnol (2014) 0.81
Elderly patients with trochanteric hip fracture have lower serum Vitamin D levels compared to patients with cervical hip fracture. Arch Gerontol Geriatr (2010) 0.81
The calcineurin-nuclear factor of activated T cells signaling pathway mediates the effect of corticotropin releasing factor and urocortins on catecholamine synthesis. J Cell Physiol (2012) 0.81
Detection of herpes viruses in children with acute appendicitis. J Clin Virol (2009) 0.80
Evaluation of bone disease in multiple myeloma: a correlation between biochemical markers of bone metabolism and other clinical parameters in untreated multiple myeloma patients. Clin Chim Acta (2002) 0.80
The metastatic potential of human pancreatic cell lines in the liver of nude mice correlates well with cathepsin B activity. Int J Gastrointest Cancer (2003) 0.80
Mapping structural determinants within third intracellular loop that direct signaling specificity of type 1 corticotropin-releasing hormone receptor. J Biol Chem (2012) 0.80
Corticotropin-releasing hormone deficiency results in impaired splenocyte response to lipopolysaccharide. J Neuroimmunol (2003) 0.80
Impact of religiosity/spirituality on biological and preclinical markers related to cardiovascular disease. Results from the SPILI III study. Hormones (Athens) (2013) 0.80
Activation of phosphatidylinositol 3-kinase/protein kinase B by corticotropin-releasing factor in human monocytes. Endocrinology (2009) 0.80
Matrix metalloproteinase-9 participates in NGF-induced α-secretase cleavage of amyloid-β protein precursor in PC12 cells. J Alzheimers Dis (2011) 0.80
The impact of stress on tumor growth: peripheral CRF mediates tumor-promoting effects of stress. Mol Cancer (2010) 0.79